Head R J, Longhurst P A, Panek R L, Stitzel R E
Br J Pharmacol. 1987 Jun;91(2):275-86. doi: 10.1111/j.1476-5381.1987.tb10282.x.
Diabetes was induced in rats by a single intraperitoneal injection of streptozotocin (65 mg kg-1). Rabbits were rendered diabetic by injecting alloxan (100 mg kg-1) into the lateral ear vein. Diabetes was confirmed by a significant elevation of serum glucose in both species 8 weeks after injection. The maximum contraction to noradrenaline (NA), 5-hydroxytryptamine (5-HT) and KCl was markedly diminished in thoracic aortic rings (AR) from diabetic rats with no change in the EC50 of the agonists. There were no differences in the contractile properties of AR from diabetic rabbits to NA, 5-HT or KCl. Diabetes did not alter the responsiveness of AR from the rat to angiotensin II (AII). However, AR from diabetic rabbits displayed a decreased maximal contraction and an increased EC50 to AII. The magnitude of the acetylcholine-induced relaxation to precontracted AR was not different between diabetic and control rats and rabbits. The contractile responses of AR to NA, 5-HT and KCl were depressed in diabetic rats, regardless of the control tissue to which they were compared. The decrease in maximal contraction to NA, 5-HT and KCl seen in diabetic animals was prevented by insulin replacement. The results demonstrated that while both rats and rabbits exhibited a similar degree of hyperglycemia after treatment with a diabetogenic agent, aortic preparations from the rabbit are not affected in the same way as the aorta from the diabetic rat when exposed to NA, 5-HT and KCl. This feature may be related to the marked differences between the extent of sympathetic innervation of the aorta in the rabbit and rat. Furthermore, the decrease in maximal contraction in rat aorta was non-specific with respect to agonists since it could also be demonstrated with KCl. Therefore, it follows that the diabetic state may affect processes responsible for contraction beyond the level of receptor activation.
通过单次腹腔注射链脲佐菌素(65毫克/千克)诱导大鼠患糖尿病。通过向兔耳外侧静脉注射四氧嘧啶(100毫克/千克)使兔患糖尿病。注射8周后,两种动物血清葡萄糖显著升高,从而确诊糖尿病。糖尿病大鼠胸主动脉环(AR)对去甲肾上腺素(NA)、5-羟色胺(5-HT)和氯化钾的最大收缩反应明显减弱,而激动剂的半数有效浓度(EC50)无变化。糖尿病兔的AR对NA、5-HT或氯化钾的收缩特性无差异。糖尿病未改变大鼠AR对血管紧张素II(AII)的反应性。然而,糖尿病兔的AR对AII的最大收缩反应降低,EC50增加。糖尿病大鼠和对照大鼠及兔的AR对乙酰胆碱诱导的预收缩舒张反应幅度无差异。无论与何种对照组织比较,糖尿病大鼠AR对NA、5-HT和氯化钾的收缩反应均降低。胰岛素替代可防止糖尿病动物对NA、5-HT和氯化钾的最大收缩反应降低。结果表明,虽然用致糖尿病药物治疗后大鼠和兔都表现出相似程度的高血糖,但兔的主动脉制剂在暴露于NA、5-HT和氯化钾时,其受影响的方式与糖尿病大鼠的主动脉不同。这一特征可能与兔和大鼠主动脉交感神经支配程度的显著差异有关。此外,大鼠主动脉最大收缩反应降低对激动剂是非特异性的,因为用氯化钾也可证明这一点。因此,可以得出结论,糖尿病状态可能会影响受体激活水平以上负责收缩的过程。